Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOZ SITAGLIPTIN-METFORMIN	1000MG 50MG	TABLET	Resolved	2024-10-28	2024-11-26	241407
SANDOZ SITAGLIPTIN-METFORMIN	850MG 50MG	TABLET	Resolved	2023-07-17	2023-08-08	198833
SANDOZ SITAGLIPTIN-METFORMIN	500MG 50MG	TABLET	Resolved	2024-06-25	2024-07-03	231221
SANDOZ SITAGLIPTIN-METFORMIN	500MG 50MG	TABLET	Resolved	2024-02-26	2024-03-06	220558
SANDOZ SITAGLIPTIN-METFORMIN	500MG 50MG	TABLET	Resolved	2023-12-19	2024-01-24	213821
SANDOZ SITAGLIPTIN-METFORMIN	500MG 50MG	TABLET	Resolved	2023-10-02	2023-10-11	205811
SANDOZ SITAGLIPTIN-METFORMIN	500MG 50MG	TABLET	Resolved	2023-05-25	2023-07-11	193057
SANDOZ SITAGLIPTIN-METFORMIN XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Resolved	2025-10-06	2025-10-20	268605
SANDOZ SITAGLIPTIN-METFORMIN XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Resolved	2024-05-21	2024-05-28	228423
SANDOZ SITAGLIPTIN-METFORMIN XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2025-11-17	2025-12-15	272000

Previous
1
…
7
8
9
10
Next

Showing 81 to 90 of 98

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
JANUMET	850MG 50MG	TABLET	Discontinued	2024-12-12	2025-08-14	245516
STEGLUJAN	5MG 100MG	TABLET	Discontinued	2021-02-04	2021-02-04	133310
STEGLUJAN	15MG 100MG	TABLET	Discontinued	2021-02-04	2021-02-04	133307

1

Showing 1 to 3 of 3